Biofrontera AG (XTER:B8F) Days Sales Outstanding : 13.07 (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG Days Sales Outstanding?

Biofrontera AG's average Accounts Receivable for the three months ended in Sep. 2023 was €1.01 Mil. Biofrontera AG's Revenue for the three months ended in Sep. 2023 was €7.02 Mil. Hence, Biofrontera AG's Days Sales Outstanding for the three months ended in Sep. 2023 was 13.07.

The historical rank and industry rank for Biofrontera AG's Days Sales Outstanding or its related term are showing as below:

XTER:B8F' s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.52 Med: 48.92 Max: 74.99
Current: 12.63

During the past 13 years, Biofrontera AG's highest Days Sales Outstanding was 74.99. The lowest was 10.52. And the median was 48.92.

XTER:B8F's Days Sales Outstanding is ranked better than
95.5% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs XTER:B8F: 12.63

Biofrontera AG's Days Sales Outstanding increased from Sep. 2022 (11.15) to Sep. 2023 (13.07).

Biofrontera AG Days Sales Outstanding Historical Data

The historical data trend for Biofrontera AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG Days Sales Outstanding Chart

Biofrontera AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

42.87

49.20

51.31

27.22

10.52

Biofrontera AG Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial															11.15	19.48	15.72	9.33	13.07

Competitive Comparison of Biofrontera AG's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofrontera AG's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biofrontera AG's Days Sales Outstanding falls into.

Biofrontera AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biofrontera AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0.793	+	0.691)	/	2 )	/	25.738	*	365
=	0.742					/	25.738	*	365
=	10.52

Biofrontera AG's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (1.144	+	0.866)	/	2 )	/	7.015	*	365 / 4
=	1.005					/	7.015	*	365 / 4
=	13.07

Biofrontera AG (XTER:B8F) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biofrontera AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofrontera AG (XTER:B8F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8F) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

B8F:Germany B8F:Germany B8F:Germany

Address

Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377

Website

https://www.biofrontera.com

Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8F) Headlines

No Headlines